21 States Sue Federal Government Over Denial of Medicaid Funds for Trans Youth Care

**A coalition of 21 states, Washington D.C., and Pennsylvania has sued the federal government over a CMS rule that blocks federal Medicaid and CHIP funds for gender-affirming care aimed at transgender youth.

• The lawsuit was filed in a federal court in Massachusetts and questions the legal authority of CMS.
• The states argue that the rule interferes with their medical decisions and the administration of Medicaid and CHIP.
• Mehmet Oz defended the measure, while Democratic attorneys and medical organizations reject the restrictions.

The Lawsuit Against the New Rule

A coalition of 21 states, Washington D.C., and Pennsylvania has sued the federal government over a rule that restricts federal Medicaid funding for gender-affirming care aimed at transgender youth. The legal action was filed in a federal court in Massachusetts and targets a regulation issued in August by the Centers for Medicare and Medicaid Services, known as CMS.

The rule prevents states from using federal Medicaid or Children's Health Insurance Program (CHIP) funds to cover what the agency describes as "experimental and life-altering procedures that reject sex." The coalition believes that this classification allows the federal government to exclude legally necessary medical treatments from federal reimbursement, even when states have deemed them medically necessary within their own programs.

The lawsuit argues that CMS exceeded the authority granted by Congress by imposing a prohibition specifically targeting certain services for transgender adolescents. According to the states, the rule not only affects the availability of coverage but also unilaterally alters the relationship through which state governments administer Medicaid and CHIP with federal financial participation.

The litigation centers on a dispute over who decides what medical care is necessary within these public programs. The plaintiffs assert that Congress never authorized federal officials to deny financial participation or reimbursement for legal treatments solely because they are provided to transgender adolescents, a measure they characterize as a threat to the structure of Medicaid.

The States' Argument

In the court document, the coalition accuses CMS of stripping states of their role as authorized administrators of Medicaid and CHIP. The attorneys general argue that the agency is usurping state determinations of medical necessity and allowing the federal government to unilaterally prohibit funding for certain benefits, rather than respecting the competencies assigned by existing legislation.

The lawsuit also describes the rule as a financial mechanism to limit access to treatments that the federal government has not directly prohibited nationwide. The states contend that by withdrawing federal reimbursement, Washington can pressure state governments to abandon coverages that remain legal in their jurisdictions, even though they retain the responsibility to decide how their health programs operate.

The attorneys general from California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New York, Oregon, Rhode Island, Vermont, Virginia, Washington, and Wisconsin are among the plaintiffs. They are joined by Washington D.C. and Pennsylvania, represented by their governor, Josh Shapiro, in a coalition seeking to have the court halt the enforcement of the rule.

The action represents a new chapter in a dispute that had already reached the courts through other administrative avenues. According to reports on the case, the plaintiffs argue that the federal government attempted to restrict access to this care through previous guidelines and is now seeking to achieve the same goal through financial sanctions against states that continue to cover it.

Clash Between Authorities and Medical Community

Federal officials have presented gender affirmation care as a set of experimental interventions, a characterization that underpins the exclusion from federal funding. However, the American Medical Association, the American Academy of Pediatrics, and other major medical organizations support access to this care and oppose government restrictions, according to information released about the case.

Mehmet Oz, the CMS administrator, defended the rule by arguing that the government must protect minors from interventions that, in his view, pose serious risks and do not offer proven benefits. "Children deserve our protection, not experimental interventions that pose serious risks and do not provide proven benefits," Oz stated, adding that the funding cuts follow the science, reduce taxpayer spending, and seek to avoid potentially irreversible harm.

The lawsuit names Oz, Health and Human Services Secretary Robert F. Kennedy Jr., as well as the Department of Health and Human Services and CMS itself as defendants. The inclusion of these authorities and agencies reflects that the conflict is not limited to a technical decision about reimbursements but questions the legal and administrative basis used to modify coverage of public programs.

The disagreement also exposes two opposing readings of medical evidence and the role of the federal state. While the government presents the exclusion as a measure of protection and public savings, the plaintiffs and the cited medical organizations argue that restricting coverage by federal decision can prevent treatments that states consider legal and medically necessary for some transgender youth.

Judicial Background and Next Steps

The coalition recalls that a federal judge overturned a previous effort by the federal government to restrict gender affirmation care nationwide in April. Judge Mustafa T. Kasubhai nullified the so-called "Kennedy Statement" after concluding that the Department of Health and Human Services had exceeded its authority, violated federal rulemaking requirements, and conflicted with existing legislation.

For the plaintiff states, the new rule represents a distinct strategy to pursue a similar outcome. Instead of directly ordering providers or states to abandon the care, CMS conditions federal financial participation and threatens to deny reimbursement for certain benefits, according to the argument presented before the federal court in Massachusetts.

New York Attorney General Letitia James stated that the federal government has no authority to dictate what medically necessary care her state offers to its residents. James argued that the rule threatens transgender youth's access to medical care and undermines the state's ability to administer Medicaid, so New York will continue to defend patients and its regulatory authority.

Andrea Joy Campbell, the Attorney General of Massachusetts, described the measure as another attack by the federal government on access to gender-affirming care. Campbell stated that such care remains legal and is protected in Massachusetts, adding that she will challenge actions that, in her view, seek to withdraw medical services from vulnerable children and limit the rights of transgender youth and their families.

The court will now assess whether the CMS acted within the limits set by Congress and whether it can condition federal reimbursement for Medicaid and CHIP in the manner challenged by the states. As the process unfolds, the dispute keeps a national confrontation open regarding healthcare funding, state competencies, and access to medical care for transgender youth.

This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.